Analytical methods | |||
---|---|---|---|
Comparative study | #1 | #2 | |
Chromatography | LC | LC | |
Ion source | ESI | ESI | |
Positive/Negative mode | positive | positive | |
Mass analyzer | Q-TOF | Q-TOF | |
Identification level | MS/MS | MS/MS |
Sample information | |||
---|---|---|---|
Comparative study | #1 | #2 | |
Country | US | US | |
Specimen | lymph node aspirates | lymph node aspirates | |
Marker function | diagnosis | diagnosis | |
Participants(Case) | Cancer type | adenocarcinoma, squamous cell carcinoma | adenocarcinoma |
Stage | II, III, IV | II, III, IV | |
Number | 50 | 31 | |
Gender (M,F) | 31, 19 | 17, 14 | |
Mean age (range) (M,F) | – | – | |
Smoking status | – | – | |
Participants(Control) | Type | non-malignant | squamous cell carcinoma |
Number | 29 | 19 | |
Gender (M,F) | 15, 14 | 14, 5 | |
Mean age (range) (M,F) | – | – | |
Smoking status | – | – |
Data processing and metabolite identification | |
---|---|
Data processing software | MassHunter, MassProfilerProfessional |
Database search | HMDB |
Statistical analysis | |
---|---|
Differential analysis method | OPLS-DA, PLS-DA |
Classification method | – |
Survival analysis method | – |
Metabolite | Author-emphasized biomarkers | Mean concentration (case) | Mean concentration (control) | Fold change (case/control) | P-value | FDR | VIP |
---|---|---|---|---|---|---|---|
reduced glutathione | V | – | – | 4.62 | 0.04 | – | – |
oxidized glutathione | V | – | – | 2.53 | 9.00e-04 | – | – |
oxidized glutathione | V | – | – | 1.57 | 0.17 | – | – |
reduced glutathione | V | – | – | 1.54 | 0.57 | – | – |
glutamate | V | – | – | 1.44 | 0.04 | – | – |
kynurenine | V | – | – | 1.36 | 0.14 | – | – |
glutamate | V | – | – | 1.10 | 0.74 | – | – |
tryptophan | V | – | – | 0.98 | 0.92 | – | – |
kynurenine | V | – | – | 0.97 | 0.92 | – | – |
glutamine | V | – | – | 0.92 | 0.70 | – | – |
glutamine | V | – | – | 0.69 | 7.60e-03 | – | – |
tryptophan | V | – | – | 0.59 | 2.70e-03 | – | – |
Metabolite | Author-emphasized biomarkers | Cutoff value | AUROC (95%CI) | Sensitivity (%) | Specificity (%) | Accuracy (%) |
---|---|---|---|---|---|---|
reduced glutathione | V | – | – | – | – | – |
oxidized glutathione | V | – | – | – | – | – |
oxidized glutathione | V | – | – | – | – | – |
reduced glutathione | V | – | – | – | – | – |
glutamate | V | – | – | – | – | – |
kynurenine | V | – | – | – | – | – |
glutamate | V | – | – | – | – | – |
tryptophan | V | – | – | – | – | – |
kynurenine | V | – | – | – | – | – |
glutamine | V | – | – | – | – | – |
glutamine | V | – | – | – | – | – |
tryptophan | V | – | – | – | – | – |